Press Releases - 2022-05-20

Date	Title	Company
20-May-2022	SAE Media Group Announces the date for 2nd Annual Aseptic Processing Conference	SAE Media Group
20-May-2022	STRATEC’S ANNUAL GENERAL MEETING APPROVES DIVIDEND INCREASE AND EXTENSION TO SUPERVISORY BOARD	STRATEC SE
20-May-2022	Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion in 2032: Visiongain Research Inc	Visiongain
20-May-2022	UICC announces a new global coalition to increase access to and the use of essential cancer medicines in low- and lower middle-income countries	Union for International Cancer Control (UICC) a
20-May-2022	New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies	Abbott
20-May-2022	University Gastroenterology Partners With Virgo Surgical Video Solutions to Reimagine IBD Clinical Trial Recruitment	Newswire
20-May-2022	Bavarian Nordic Secures Vaccine Order from European Country After Confirmed Monkeypox Cases	Bavarian Nordic
20-May-2022	Enterome to present world first clinical data with EO2401, its first-in-class off-the-shelf OncoMimics™ therapeutic cancer vaccine, at ASCO 2022	Enterome
20-May-2022	Evox Therapeutics Announces Data Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting	Evox Therapeutics
20-May-2022	Calliditas receives positive CHMP opinion in IgA nephropathy	Calliditas Therapeutics AB
20-May-2022	Astellas Analysis Shows No Evidence of Increased Risk of Cardiovascular Events or Mortality with Roxadustat Compared with Erythropoiesis-Stimulating Agents (ESAs) at 59th ERA Congress 2022	Astellas Pharma Inc.
20-May-2022	World-renowned Health Experts to gather in London at Integrative and Personalised Medicine 2022 Congress	Integrative and Personalised Medicine 2022
20-May-2022	EORTC and Alliance Healthcare’s continued partnership in support of SPECTA clinical research infrastructure	European Organisation for Research and Treatment of Cancer (EORTC)
20-May-2022	OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing	OKYO Pharma Limited
20-May-2022	OKYO Pharma Limited - PDMR Dealing	OKYO Pharma Limited
20-May-2022	Birmingham research brings hope for spinal cord injury treatment	University of Birmingham
20-May-2022	Astellas Analysis Shows No Evidence of Increased Risk of Cardiovascular Events or Mortality with Roxadustat Compared with Erythropoiesis-Stimulating Agents (ESAs) at 59th ERA Congress 2022	Astellas Pharma Inc.
20-May-2022	Saba Yussouf, INVISI CEO signs $16 million distribution deal with global distribution firm.	Invisi Smart Technologies UK Limited
20-May-2022	Chiesi acquires therapeutic monoclonal antibodies portfolio being investigated as potential treatment for pulmonary arterial hypertension	Chiesi Farmaceutici S.p.A.
20-May-2022	Procysbi® (mercaptamine bitartrate gastro-resistant hard capsules) recommended for use within NHS Wales as an option for the treatment of patients with nephropathic cystinosis	Chiesi Limited